Page 2408 - Williams Hematology ( PDFDrive )

2378 Part XIII: Transfusion Medicine Chapter 138: Blood Procurement and Red Cell Transfusion 2379

39. Reid ME, Halter Hipsky C, Hue-Roye K, Hoppe C: Genomic analyses of RH alleles to 66. Bux J, Sachs UJ: The pathogenesis of transfusion-related acute lung injury (TRALI). Br
improve transfusion therapy in patients with sickle cell disease. Blood Cells Mol Dis J Haematol 136(6):788, 2007.
52(4):195, 2014. 67. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ: The residual risk of transfusion-
40. Storb R, Prentice RL, Thomas ED: Marrow transplantation for treatment of aplastic related acute lung injury at the American Red Cross (2008–2011): Limitations of a
anemia. an analysis of factors associated with graft rejection. N Engl J Med 296(2):61, predominantly male-donor plasma mitigation strategy. Transfusion 53(7):1442, 2013.
1977. 68. Report of the US Department of Health and Human Services: The 2010 National
41. Champlin RE, Horowitz MM, van Bekkum DW, et al: Graft failure following bone mar- Blood Collection and Utilization Survey Report. US Department of Health and Human
row transplantation for severe aplastic anemia: Risk factors and treatment results. Blood Services, Washington, DC, 2011.
73(2):606, 1989. 69. Flesland O: A comparison of complication rates based on published haemovigilance
42. Patel SR, Zimring JC: Transfusion-induced bone marrow transplant rejection due to data. Intensive Care Med 33 Suppl 1:S17, 2007.
minor histocompatibility antigens. Transfus Med Rev 27(4):241, 2013. 70. Popovsky MA, Audet AM, Andrzejewski C Jr: Transfusion-associated circulatory over-
43. Webert KE, Cook RJ, Couban S, et al: A multicenter pilot-randomized controlled load in orthopedic surgery patients: A multi-institutional study. Immunohematology
trial of the feasibility of an augmented red blood cell transfusion strategy for patients 12(2):87, 1996.
treated with induction chemotherapy for acute leukemia or stem cell transplantation. 71. Narick C, Triulzi DJ, Yazer MH: Transfusion-associated circulatory overload after
Transfusion 48(1):81, 2008. plasma transfusion. Transfusion 52(1):160, 2012.
44. Rowley SD: Hematopoietic stem cell transplantation between red cell incompatible 72. Robillard P, Nawej K, Chapdelaine A: Transfusion-associated circulatory overload
donor-recipient pairs. Bone Marrow Transplant 28(4):315, 2001. (TACO): Current leading cause of transfusion-associated fatalities reported to the
45. Petz LD: Immune hemolysis associated with transplantation. Semin Hematol 42(3):145, Quebec hemovigilance system. Transfus Med 19:280, 2009.
2005. 73. Li G, Rachmale S, Kojicic M, et al: Incidence and transfusion risk factors for
46. Vamvakas EC: White-blood-cell-containing allogeneic blood transfusion and postop- transfusion- associated circulatory overload among medical intensive care unit patients.
erative infection or mortality: An updated meta-analysis. Vox Sang 92(3):224, 2007. Transfusion 51(2):338, 2011.
47. Bowden RA, Slichter SJ, Sayers M, et al: A comparison of filtered leukocyte-reduced and 74. Li G, Daniels CE, Kojicic M, et al: The accuracy of natriuretic peptides (brain natri-
cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- uretic peptide and N-terminal pro-brain natriuretic) in the differentiation between
associated CMV infection after marrow transplant. Blood 86(9):3598, 1995. transfusion-related acute lung injury and transfusion-related circulatory overload in
48. Nash T, Hoffmann S, Butch S, et al: Safety of leukoreduced, cytomegalovirus (CMV)- the critically ill. Transfusion 49(1):13, 2009.
untested components in CMV-negative allogeneic human progenitor cell transplant 75. Kuehnert MJ, Roth VR, Haley NR, et al: Transfusion-transmitted bacterial infection in
recipients. Transfusion 52(10):2270, 2012. the United States, 1998 through 2000. Transfusion 41(12):1493, 2001.
49. Thiele T, Kruger W, Zimmermann K, et al: Transmission of cytomegalovirus (CMV) 76. Triulzi D, Duquesnoy R, Nichols L, et al: Fatal transfusion-associated graft-versus-host
infection by leukoreduced blood products not tested for CMV antibodies: A single- disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion
center prospective study in high-risk patients undergoing allogeneic hematopoietic 46(6):885, 2006.
stem cell transplantation (CME). Transfusion 51(12):2620, 2011. 77. Petz LD, Calhoun L, Yam P, et al: Transfusion-associated graft-versus-host disease
50. Ziemann M, Krueger S, Maier AB, et al: High prevalence of cytomegalovirus DNA in immunocompetent patients: Report of a fatal case associated with transfusion of
in plasma samples of blood donors in connection with seroconversion. Transfusion blood from a second-degree relative, and a survey of predisposing factors. Transfusion
47(11):1972, 2007. 33(9):742, 1993.
51. Treleaven J, Gennery A, Marsh J, et al: Guidelines on the use of irradiated blood com- 78. Moroff G, Luban NL: The irradiation of blood and blood components to prevent graft-
ponents prepared by the british committee for standards in haematology blood trans- versus-host disease: Technical issues and guidelines. Transfus Med Rev 11(1):15, 1997.
fusion task force. Br J Haematol 152(1):35, 2011. 79. Weiskopf RB, Feiner J, Toy P, et al: Fresh and stored red blood cell transfusion equiv-
52. Obrador GT, Macdougall IC: Effect of red cell transfusions on future kidney transplan- alently induce subclinical pulmonary gas exchange deficit in normal humans. Anesth
tation. Clin J Am Soc Nephrol 8(5):852, 2013. Analg 114(3):511, 2012.
53. Reed A, Pirsch J, Armbrust MJ, et al: Multivariate analysis of donor-specific versus ran- 80. Berra L, Coppadoro A, Yu B, et al: Transfusion of stored autologous blood does not alter
dom transfusion protocols in haploidentical living-related transplants. Transplantation reactive hyperemia index in healthy volunteers. Anesthesiology 117(1):56, 2012.
51(2):382, 1991. 81. Weiskopf RB, Feiner J, Hopf H, et al: Fresh blood and aged stored blood are equally
54. Christiaans MH, van Hooff JP, Nieman F, van den Berg-Loonen EM: HLA-DR matched efficacious in immediately reversing anemia-induced brain oxygenation deficits in
transfusions: Development of donor-specific T- and B-cell antibodies and renal allog- humans. Anesthesiology 104(5):911, 2006.
raft outcome. Transplantation 67(7):1029, 1999. 82. Hod EA, Brittenham GM, Billote GB, et al: Transfusion of human volunteers with
55. Pineda AA, Brzica SM Jr, Taswell HF: Hemolytic transfusion reaction. recent experi- older, stored red blood cells produces extravascular hemolysis and circulating non-
ence in a large blood bank. Mayo Clin Proc 53(6):378, 1978. transferrin- bound iron. Blood 118(25):6675, 2011.
56. Linden JV, Wagner K, Voytovich AE, Sheehan J: Transfusion errors in New York State: 83. Koch CG, Li L, Sessler DI, et al: Duration of red-cell storage and complications after
An analysis of 10 years’ experience. Transfusion 40(10):1207, 2000. cardiac surgery. N Engl J Med 358(12):1229, 2008.
57. Davenport RD: The role of cytokines in hemolytic transfusion reactions. Immunol 84. Aubron C, Nichol A, Cooper DJ, Bellomo R: Age of red blood cells and transfusion in
Invest 24(1-2):319, 1995. critically ill patients. Ann Intensive Care 3:1, 2013.
58. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 85. Wang D, Sun J, Solomon SB, Klein HG, Natanson C: Transfusion of older stored blood
30(7):583, 1990. and risk of death: A meta-analysis. Transfusion 52(6):1184, 2012.
59. Cohn CS, Stubbs J, Schwartz J, et al: A comparison of adverse reaction rates for PAS C 86. Fernandez Perez ER, Winters JL, Gajic O: The addition of decision support into com-
versus plasma platelet units. Transfusion 54(8):1927, 2014. puterized physician order entry reduces red blood cell transfusion resource utilization
60. Marti-Carvajal AJ, Sola I, Gonzalez LE, et al: Pharmacological interventions for the in the intensive care unit. Am J Hematol 82(7):631, 2007.
prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane 87. Cohn CS, Welbig J, Bowman R, et al: A data-driven approach to patient blood manage-
Database Syst Rev (6):CD007539, 2010. ment. Transfusion 54(2):316, 2014.
61. Tobian AA, King KE, Ness PM: Prevention of febrile nonhemolytic and allergic trans- 88. Carson JL, Duff A, Poses RM, et al: Effect of anaemia and cardiovascular disease on
fusion reactions with pretransfusion medication: Is this evidence-based medicine? surgical mortality and morbidity. Lancet 348(9034):1055, 1996.
Transfusion 48(11):2274, 2008. 89. van Straten AH, Hamad MA, van Zundert AJ, et al: Preoperative hemoglobin level as
62. Savage WJ, Tobian AA, Savage JH, et al: Scratching the surface of allergic transfusion a predictor of survival after coronary artery bypass grafting: A comparison with the
reactions. Transfusion 53(6):1361, 2013. matched general population. Circulation 120(2):118, 2009.
63. Goldman M, Webert KE, Arnold DM, et al: Proceedings of a consensus conference: 90. Musallam KM, Tamim HM, Richards T, et al: Preoperative anaemia and postoperative
Towards an understanding of TRALI. Transfus Med Rev 19(1):2, 2005. outcomes in non-cardiac surgery: A retrospective cohort study. Lancet 378(9800):1396,
64. Marik PE, Corwin HL: Acute lung injury following blood transfusion: Expanding the 2011.
definition. Crit Care Med 36(11):3080, 2008. 91. Spahn DR. Anemia and patient blood management in hip and knee surgery: A system-
65. Silliman CC, Voelkel NF, Allard JD, et al: Plasma and lipids from stored packed red atic review of the literature. Anesthesiology 113(2):482, 2010.
blood cells cause acute lung injury in an animal model. J Clin Invest 101(7):1458, 1998.

Kaushansky_chapter 138_p2365-2380.indd 2379 9/18/15 11:14 AM